DRGT 65

Drug Profile

DRGT 65

Alternative Names: DRGT-65

Latest Information Update: 26 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Druggability Technologies
  • Class Antipsychotics
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Psychotic disorders

Highest Development Phases

  • Phase I Bipolar depression; Schizophrenia

Most Recent Events

  • 26 Jul 2016 DRGT 65 is available for licensing as of 26 Jul 2016. http://www.drgtco.com/partnering/
  • 25 Jul 2016 Phase-I clinical trials in Bipolar depression in Ireland (unspecified route) prior to July 2016 (Druggability pipeline, July 2016)
  • 25 Jul 2016 Phase-I clinical trials in Schizophrenia in Ireland (unspecified route) prior to July 2016 (Druggability pipeline, July 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top